World Malaria Day: Invest, innovate, implement Maternal Immunisation: Prevent, protect, immunise Vaccinating women in pregnancy has emerged as a promising tool to protect women against infectious diseases and tackle infant morbidity and mortality worldwide. LSHTM Vaccine Centre World Immunisation Week activities will showcase the development of new maternal vaccines and provide the opportunity to discuss other vaccines with potential positive health outcomes.
GSK Pharma Vietnam Company Limited (GSK Vietnam), the Vietnam Association of Gynecology and Obstetrics and the Vietnam Association of Preventive Medicine, have organised a series of scientific seminars on the benefits of maternal immunisation against pertussis, especially for pregnant women.
GSK Pharma Vietnam Company Limited (GSK Vietnam), the Vietnam Association of Gynecology and Obstetrics and the Vietnam Association of Preventive Medicine, have organised a series of scientific seminars on the benefits of maternal immunisation against pertussis, especially for pregnant women.
Date Time
First UK COVID-19 vaccine study for pregnant women launches in Southampton
The first COVID-19 vaccine study in the UK recruiting pregnant women has been launched across several National Institute for Health Research (NIHR) sites, including University Hospital Southampton.
The phase 2/3 study aims to further understand the safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in healthy pregnant women, with approximately 235 volunteers involved throughout the UK.
Following updated guidance from the Joint Committee on Vaccination and Immunisation (JCVI) released in April, pregnant women are now offered approved COVID-19 vaccines at the same time as the rest of the UK population, based on their age and clinical risk group. Real-world data from the United States has been collected, in which over 100,000 pregnant women have been vaccinated (mainly with mRNA vaccines including Pfizer-BioNTech), without any safety concerns raised.